
Category: QB3 News
-
UC Santa Cruz innovators recognized for impact at 2024 Santa Cruz Works Titans Awards
Two UC Santa Cruz faculty members, Richard (Ed) Green and Chris Benner, have been selected as awardees for the eighth annual Santa Cruz Works Titans Awards, which recognize outstanding individuals who have made significant contributions to the local tech and entrepreneurial community. Santa Cruz Works, a non-profit organization focused on connecting industry professionals and expanding local…
-
New QB3 Biotech Undergraduate Summer Internships program connects students with hands-on work experience
The program connects students with paid internships at local biotech companies and UCSC labs.
-
Researchers to investigate genetic roots of autism, look for new treatments
A $12.3 million award will support research out of UC Santa Cruz, UC San Francisco, and UC Berkeley
-
Campus leaders showcase innovation, entrepreneurship efforts to special Regents committee
The Hub is also working to build a supportive innovation ecosystem. What has become known as the Innovation Champions Network provides those on campus involved in entrepreneurship efforts with a forum for information sharing, strategic planning, and special initiatives coordination. The network includes members from several long-standing campus organizations including the Center for Innovation &…
-
Ed Green named QB3-Santa Cruz Scientific Director
Richard (Ed) Green, professor of biomolecular engineering, has been selected to serve as the next director of the California Institute of Quantitative Biosciences (QB3) at UC Santa Cruz. QB3 is the University of California’s hub for innovation and entrepreneurship in life science, working with UC researchers and other scientists to launch startup companies and partner…
-
New program advises UCSC Ph.D. students on their path to entrepreneurship and venture capital
The Innovation & Business Engagement Hub, in collaboration with the California Institute for Quantitative Biosciences (QB3) at UCSC, launched a new fellowship program in 2022 organized through Nucleate, a free and collaborative student-run organization founded at Harvard University with a focus on identifying future “bioentrepreneurs.”
-
UC Santa Cruz joins the University of California Drug Discovery Consortium
Scott Lokey, professor of chemistry and biochemistry, is the UCSC campus lead for University of California Drug Discovery Consortium and a member of the executive committee. UC Santa Cruz has joined the University of California Drug Discovery Consortium (UC DDC), a cross-campus initiative aimed at building a drug discovery community that actively promotes research translation…
-
Confronting COVID
As the world continues to grapple with the COVID-19 pandemic, UC Santa Cruz faculty are deploying their resources and expertise to help humanity find its way out of the grip of the deadly infection.
-
$2 million grant revamps Chemical Screening Center
The UCSC Chemical Screening Center’s Faculty Director Scott Lokey and Director of Operations Beverley Rabbitts review results of screening assays. (Photo by Carolyn Lagattuta)
-
PNAS Announces Six 2020 Cozzarelli Prize Recipients
National Academy of Sciences | March 15, 2021 WASHINGTON, DC – The Editorial Board of the Proceedings of the National Academy of Sciences (PNAS) has selected six papers published by PNAS in 2020 to receive the Cozzarelli Prize, an award that recognizes outstanding contributions to the scientific disciplines represented by the National Academy of Sciences (NAS). Papers…
-
Ultrasensitive antigen test detects SARS-CoV-2 and influenza viruses
This illustration shows the setup of the optofluidic chip for rapid detection of single antigens of SARS-CoV-2 and Influenza A. (Image credit: Stambaugh et al., PNAS 2021)
-
UC Santa Cruz researchers receive cell research grant
Cell mechanism research provides a better platform for cancer prevention. SANTA CRUZ – The National Institute of Health rewarded UC Santa Cruz researchers with a $1.25 million grant to study cellular genomics. The research, which is led by UC Santa Cruz Professor of Molecular, Cell and Developmental Biology William Sullivan, could result in treatments that…